BAF Mutations Linked to Cancer Through DNA Accessibility Changes

New research reveals that mutations in the BAF complex, commonly found in various cancers, promote tumor development by modifying DNA accessibility for the CTCF protein. This alteration in genomic architecture and gene regulation is a crucial discovery for understanding how BAF mutations contribute to cancer progression. The finding offers potential new therapeutic targets for diseases such as breast cancer, liver cancer, lymphoma, and ovarian cancer.